Cancer Fatalism Among Asian American Adults by Origin Group, 2012–2022

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-03-18 DOI:10.1002/cam4.70738
Justine Liu, Yenan Zhu, Ryan Suk, Milkie Vu
{"title":"Cancer Fatalism Among Asian American Adults by Origin Group, 2012–2022","authors":"Justine Liu,&nbsp;Yenan Zhu,&nbsp;Ryan Suk,&nbsp;Milkie Vu","doi":"10.1002/cam4.70738","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Backgrounds</h3>\n \n <p>Cancer fatalism, the belief that cancer is predetermined and unpreventable, is associated with lower uptake of cancer prevention. Little is known about cancer fatalism prevalence within various Asian origin groups.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a disaggregated analysis of cancer fatalism among Chinese, Filipino, Indian, Vietnamese, and other Asian respondents using the 2012–2022 Health Information National Trends Survey. Pairwise comparisons were conducted to assess differences between each racial and ethnic group.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Significantly lower proportions of Indian respondents (40.36%) endorsed the statement “It seems like everything causes cancer,” when compared with Vietnamese (74.59%, p = 0.0002) and Filipino (75.18%, p = 0.0009) respondents. Lower proportions of Indian and Chinese respondents endorsed the statement “There's not much you can do to lower your chances of getting cancer” when compared with Vietnamese and Filipino respondents, though these differences were not significant.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Findings highlight the heterogeneity among Asian origin groups and emphasize the importance of disaggregated data collection by origin group, which can inform culturally tailored interventions.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 6","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70738","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70738","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Backgrounds

Cancer fatalism, the belief that cancer is predetermined and unpreventable, is associated with lower uptake of cancer prevention. Little is known about cancer fatalism prevalence within various Asian origin groups.

Methods

We conducted a disaggregated analysis of cancer fatalism among Chinese, Filipino, Indian, Vietnamese, and other Asian respondents using the 2012–2022 Health Information National Trends Survey. Pairwise comparisons were conducted to assess differences between each racial and ethnic group.

Results

Significantly lower proportions of Indian respondents (40.36%) endorsed the statement “It seems like everything causes cancer,” when compared with Vietnamese (74.59%, p = 0.0002) and Filipino (75.18%, p = 0.0009) respondents. Lower proportions of Indian and Chinese respondents endorsed the statement “There's not much you can do to lower your chances of getting cancer” when compared with Vietnamese and Filipino respondents, though these differences were not significant.

Conclusions

Findings highlight the heterogeneity among Asian origin groups and emphasize the importance of disaggregated data collection by origin group, which can inform culturally tailored interventions.

Abstract Image

2012-2022年亚裔美国成年人癌症宿命论
癌症宿命论,即认为癌症是预定的和不可预防的,与癌症预防的接受程度较低有关。人们对癌症宿命论在不同亚裔群体中的流行程度知之甚少。方法:我们使用2012-2022年健康信息全国趋势调查对中国、菲律宾、印度、越南和其他亚洲受访者的癌症宿命论进行了分类分析。两两比较是为了评估每个种族和民族群体之间的差异。结果与越南(74.59%,p = 0.0002)和菲律宾(75.18%,p = 0.0009)的受访者相比,印度受访者(40.36%)支持“似乎一切都会导致癌症”这一说法的比例明显较低。与越南和菲律宾的受访者相比,印度和中国受访者中赞同“你无法降低患癌症的几率”这一说法的比例较低,尽管这些差异并不显著。研究结果强调了亚洲裔群体之间的异质性,并强调了按裔群体分类收集数据的重要性,这可以为文化量身定制的干预措施提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信